“…The aggregation of soluble peptides and proteins into amyloid fibrils is the hallmark of more than 50 human disorders, including severe neurodegenerative pathologies. − Considerable effort was therefore spent in the last decades to elucidate the structure of the fibrils, their mechanism of formation, , and the factors influencing such aggregation processes . Amyloid fibrils are generally formed through nucleation-dependent polymerization, which is characterized by a lag-phase (attributed at the microscopic level to the energetically unfavorable nucleation step) followed by rapid growth and elongation of the nuclei, or seeds, into fibrils and a final stationary phase that reflects the equilibrium between fibrils and monomers. ,, Aggregation kinetics are often monitored by means of thioflavin T (ThT) binding measurements, a dye that specifically recognizes the cross-β structure typical of amyloid fibrils. , The factors so far considered to determine the aggregation behavior in vitro of proteins/peptides are mainly their intrinsic (sequence-based) propensity to aggregate, , the sample conditions (concentration, pH, presence of cosolvents, ionic strength), , and the incubation conditions (temperature, volume of sample, presence/absence of shaking). − …”